Advanced search
Publication Cover
Nature and Science of Sleep Volume 9, 2017 - Issue
Submit an article Journal homepage
914
Views
66
CrossRef citations to date
0
Altmetric
Review

New developments in the management of narcolepsy

Vivien C AbadDepartment of Psychiatry and Behavioral Sciences, Division of Sleep Medicine, Stanford University Outpatient Center, Redwood City, CA, USACorrespondence[email protected]
&
Christian GuilleminaultDepartment of Psychiatry and Behavioral Sciences, Division of Sleep Medicine, Stanford University Outpatient Center, Redwood City, CA, USA
Pages 39-57 | Published online: 03 Mar 2017

Citations (66)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Vivien C. Abad. (2023) Pharmacological options for narcolepsy: are they the way forward?. Expert Review of Neurotherapeutics 23:9, pages 819-834.
Read now
Vivien C. Abad. (2023) Calcium, magnesium, potassium, and sodium oxybates oral solution for cataplexy or excessive daytime sleepiness associated with narcolepsy. Expert Opinion on Pharmacotherapy 24:8, pages 875-885.
Read now
Slobodan M. Janković & Miralem Đešević. (2022) Advancements in neuroactive peptides in seizures. Expert Review of Neurotherapeutics 22:2, pages 129-143.
Read now
Maria Pia Giannoccaro, Rocco Liguori, Giuseppe Plazzi & Fabio Pizza. (2021) Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder. Nature and Science of Sleep 13, pages 557-577.
Read now
Vivien C Abad. (2021) Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives. Nature and Science of Sleep 13, pages 75-91.
Read now
Ana Sousa & Ricardo Jorge Dinis-Oliveira. (2020) Pharmacokinetic and pharmacodynamic of the cognitive enhancer modafinil: Relevant clinical and forensic aspects. Substance Abuse 41:2, pages 155-173.
Read now
Shuang Li & Junyi Yang. (2020) Pitolisant for treating patients with narcolepsy. Expert Review of Clinical Pharmacology 13:2, pages 79-84.
Read now
Junyi Yang & Junfa Gao. (2019) Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy. Expert Review of Clinical Pharmacology 12:8, pages 723-728.
Read now
Vivien C. Abad. (2019) An evaluation of sodium oxybate as a treatment option for narcolepsy. Expert Opinion on Pharmacotherapy 20:10, pages 1189-1199.
Read now
Andrea Romigi, Giuseppe Vitrani, Temistocle Lo Giudice, Diego Centonze & Valentina Franco. (2018) Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy. Drug Design, Development and Therapy 12, pages 2665-2675.
Read now
Vivien C. Abad & Christian Guilleminault. (2018) Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea. Expert Review of Respiratory Medicine 12:12, pages 1007-1019.
Read now
Tatsunori Takahashi, Sakai Noriaki, Mari Matsumura, Chenyu Li, Kayo Takahashi & Seiji Nishino. (2018) Advances in pharmaceutical treatment options for narcolepsy. Expert Opinion on Orphan Drugs 6:10, pages 597-610.
Read now
Fikret Poyraz Çökmüş, Orkun Aydın, Didem Sücüllüoğlu Dikici & Şermin Yalın Sapmaz. (2018) Quickly diagnosed and treated prepubertal Type 1 narcolepsy case. Psychiatry and Clinical Psychopharmacology 28:2, pages 227-229.
Read now

Articles from other publishers (53)

Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Kimio Tohyama, Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike & Haruhide Kimura. (2023) TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy. Journal of Pharmacology and Experimental Therapeutics 385:3, pages 193-204.
Crossref
E.C. Arnold, G. Soler-Llavina, K. Kambara & D. Bertrand. (2023) The importance of ligand gated ion channels in sleep and sleep disorders. Biochemical Pharmacology 212, pages 115532.
Crossref
Meshal H. Almabadi, Florina Maria Truta, Gyako Adamu, Todd Cowen, Mihaela Tertis, Ana-Maria Drăgan, Kaseb D.M. Alanazi, Maria-Georgia Ștefan, Elena Piletska, Béla Kiss, Cecilia Cristea, Karolien De Wael, Sergey A. Piletsky & Alvaro Garcia Cruz. (2023) Integration of smart nanomaterials for highly selective disposable sensors and their forensic applications in amphetamine determination. Electrochimica Acta 446, pages 142009.
Crossref
Ajay C. Sampat & Alon Y. Avidan. (2023) Multiple Sleep Latency Test/Maintenance of Wakefulness Test and Central Hypersomnias: Evolving Diagnostic and Therapeutic Approaches. Journal of Clinical Neurophysiology 40:3, pages 203-214.
Crossref
Jessica L. Justinussen, Christine Egebjerg & Birgitte R. Kornum. (2023) How hypocretin agonists may improve the quality of wake in narcolepsy. Trends in Molecular Medicine 29:1, pages 61-69.
Crossref
Alex Dimitriu. 2023. Encyclopedia of Sleep and Circadian Rhythms. Encyclopedia of Sleep and Circadian Rhythms 307 317 .
Vishal Chavda, Bipin Chaurasia, Giuseppe E. Umana, Santino Ottavio Tomasi, Bingwei Lu & Nicola Montemurro. (2022) Narcolepsy—A Neuropathological Obscure Sleep Disorder: A Narrative Review of Current Literature. Brain Sciences 12:11, pages 1473.
Crossref
Paola Proserpio, Michele Terzaghi, Raffaele Manni & Lino Nobili. (2022) Drugs Used in Parasomnia. Sleep Medicine Clinics 17:3, pages 367-378.
Crossref
I. G. Joe Mayhew & Robert J. MacKay. 2022. Large Animal Neurology. Large Animal Neurology 215 291 .
Noeen Sarfraz, David Okuampa, Hannah Hansen, Mark Alvarez, Elyse M. Cornett, Juyeon Kakazu, Adam M. Kaye & Alan D. Kaye. (2022) pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy. Health Psychology Research 10:2.
Crossref
Laura H. Jacobson, Daniel Hoyer & Luis de Lecea. (2022) Hypocretins (orexins): The ultimate translational neuropeptides. Journal of Internal Medicine 291:5, pages 533-556.
Crossref
Tatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda, Hiromichi Sugimoto, Kei Masuda, Norio Ohyabu, Yoshihiro Banno, Norihito Tokunaga, Tetsuji Kawamoto, Yoshihide Tomata, Yasumi Kumagai, Motoo Iida, Yoichi Nagano, Mariko Yoneyama-Hirozane, Yuji Shimizu, Katsunori Sasa, Takashi Ishikawa, Hiroshi Yukitake, Mitsuhiro Ito, Kazunobu Aoyama & Takahiro Matsumoto. (2022) Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist. ACS Medicinal Chemistry Letters 13:3, pages 457-462.
Crossref
Konstantin Mechler, Tobias Banaschewski, Sarah Hohmann & Alexander Häge. (2022) Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacology & Therapeutics 230, pages 107940.
Crossref
Juan José Ortega-Albás, Raquel López García, Alfonso Martínez Martínez, Sonia Carratalá Monfort, Juan Antonio Royo Prats, Laura Albiol Varela & Patricia Ortega Gabás. 2022. Sleep Medicine and the Evolution of Contemporary Sleep Pharmacotherapy. Sleep Medicine and the Evolution of Contemporary Sleep Pharmacotherapy.
Oki Ishikawa, Stella Hahn & Harly Greenberg. (2022) Pharmacologic Therapy for Narcolepsy. Neurology 18:1, pages 68.
Crossref
Imran Ahmed & Michael Thorpy. 2022. Essentials of Sleep Medicine. Essentials of Sleep Medicine 327 348 .
Sheila Sivam, Ksenia Chamula, John Swieca, Simon Frenkel & Bandana Saini. (2021) Narcolepsy management in Australia: time to wake up. Medical Journal of Australia 215:2, pages 62.
Crossref
Cyril Hanin, Isabelle Arnulf, Jean‐Baptiste Maranci, Michel Lecendreux, Douglas F. Levinson, David Cohen & Claudine Laurent‐Levinson. (2021) Narcolepsy and psychosis: A systematic review. Acta Psychiatrica Scandinavica 144:1, pages 28-41.
Crossref
Diana Anderson. (2021) Narcolepsy. JAAPA 34:6, pages 20-25.
Crossref
Eric Murillo-Rodríguez, Sérgio Machado, Claudio Imperatori, Tetsuya Yamamoto & Henning Budde. 2021. Cannabinoids and Sleep. Cannabinoids and Sleep 133 141 .
Arpita Parmar, Brian J. Murray & Indra Narang. (2020) Clinical Characteristics of Cataplectic Attacks in Type 1 Narcolepsy. Current Neurology and Neuroscience Reports 20:9.
Crossref
Paola Proserpio, Michele Terzaghi, Raffaele Manni & Lino Nobili. (2020) Drugs Used in Parasomnia. Sleep Medicine Clinics 15:2, pages 289-300.
Crossref
Michael J. Thorpy & Richard K. Bogan. (2020) Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Medicine 68, pages 97-109.
Crossref
Mark Walzer, Gerard J. Marek, Ruishan Wu, Masanori Nagata & David Han. (2020) Single‐ and Multiple‐Dose Safety, Tolerability, and Pharmacokinetic Profiles of ASP8062: Results From 2 Phase 1 Studies. Clinical Pharmacology in Drug Development 9:3, pages 297-306.
Crossref
Hilde T Juvodden, Marte K Viken, Sebjørg E H Nordstrand, Rannveig Viste, Lars T Westlye, Per M Thorsby, Benedicte A Lie & Stine Knudsen-Heier. (2020) HLA and sleep parameter associations in post-H1N1 narcolepsy type 1 patients and first-degree relatives. Sleep 43:3.
Crossref
Eric Murillo-Rodríguez, Diana Millán-Aldaco, Marcela Palomero-Rivero, Daniela Morales-Lara, Raphael Mechoulam & René Drucker-Colín. (2020) Cannabidiol Partially Blocks the Excessive Sleepiness in Hypocretindeficient Rats: Preliminary Data. CNS & Neurological Disorders - Drug Targets 18:9, pages 705-712.
Crossref
Vahid Farnia, Firoozeh Farshchian, Nazanin Farshchian, Mostafa Alikhani, Dena Sadeghi Bahmani & Serge Brand. (2020) Comparisons of Voxel-Based Morphometric Brain Volumes of Individuals with Methamphetamine-Induced Psychotic Disorder and Schizophrenia Spectrum Disorder and Healthy Controls. Neuropsychobiology 79:2, pages 170-178.
Crossref
Alex Iranzo. (2019) Sleep and neurological autoimmune diseases. Neuropsychopharmacology 45:1, pages 129-140.
Crossref
Michael J. Thorpy. (2020) Recently Approved and Upcoming Treatments for Narcolepsy. CNS Drugs 34:1, pages 9-27.
Crossref
Maria Pia Giannoccaro, Giombattista Sallemi, Rocco Liguori, Giuseppe Plazzi & Fabio Pizza. (2020) Immunotherapy in Narcolepsy. Current Treatment Options in Neurology 22:1.
Crossref
Felicitas Ernst, Leonard Viohl & Felix Betzler. 2020. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen 1 18 .
Rakesh Bhattacharjee. 2020. Sleep Medicine and Mental Health. Sleep Medicine and Mental Health 169 188 .
Jindarat Chaiard & Terri E. Weaver. (2019) Update on Research and Practices in Major Sleep Disorders: Part II—Insomnia, Willis‐Ekbom Disease (Restless Leg Syndrome), and Narcolepsy. Journal of Nursing Scholarship 51:6, pages 624-633.
Crossref
Laura Pérez-Carbonell. (2019) Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy. Current Treatment Options in Neurology 21:11.
Crossref
Mireille Salas-Crisóstomo, Pablo Torterolo, André Barciela Veras, Nuno Barbosa Rocha, Sérgio Machado & Eric Murillo-Rodríguez. (2019) Therapeutic Approaches for the Management of Sleep Disorders in Geriatric Population. Current Medicinal Chemistry 26:25, pages 4775-4785.
Crossref
Younggi Choi & Brian K. Raymer. (2019) Sleep modulating agents. Bioorganic & Medicinal Chemistry Letters 29:16, pages 2025-2033.
Crossref
Lang Jin, Liang Shi, Ying Zhang, Bei-Bei Chen, Xiao-Li Wang & Yong-Hong Liu. (2019) Antidepressants for the treatment of narcolepsy: A prospective study of 148 patients in northern China. Journal of Clinical Neuroscience 63, pages 27-31.
Crossref
Karin Blomberg, Mats Eriksson, Rickard Böö & Åke Grönlund. (2019) Using a Facebook Forum to Cope With Narcolepsy After Pandemrix Vaccination: Infodemiology Study. Journal of Medical Internet Research 21:4, pages e11419.
Crossref
Jae Wook Cho & Jeanne F. Duffy. (2019) Sleep, Sleep Disorders, and Sexual Dysfunction. The World Journal of Men's Health 37:3, pages 261.
Crossref
Darren M. Riddy, Anna E. Cook, David M. Shackleford, Tracie L. Pierce, Elisabeth Mocaer, Clotilde Mannoury la Cour, Aurore Sors, William N. Charman, Roger J. Summers, Patrick M. Sexton, Arthur Christopoulos & Christopher J. Langmead. (2019) Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists. Neuropharmacology 144, pages 244-255.
Crossref
Andrea Lawson, Roohie Parmar & Eileen P. Sloan. 2019. Perinatal Psychopharmacology. Perinatal Psychopharmacology 341 376 .
Philippe Lehert & Bruno Falissard. (2018) Multiple treatment comparison in narcolepsy: a network meta-analysis. Sleep 41:12.
Crossref
Mohammad A. Khanfar, David Reiner, Stefanie Hagenow & Holger Stark. (2018) Design, synthesis, and biological evaluation of novel oxadiazole- and thiazole-based histamine H3R ligands. Bioorganic & Medicinal Chemistry 26:14, pages 4034-4046.
Crossref
Catherine M Hill. (2018) Treatment of paediatric narcolepsy with sodium oxybate. The Lancet Child & Adolescent Health 2:7, pages 466-467.
Crossref
Raffaele Manni, Gianpaolo Toscano & Michele Terzaghi. (2018) Therapeutic Symptomatic Strategies in the Parasomnias. Current Treatment Options in Neurology 20:7.
Crossref
Paola Proserpio, Michele Terzaghi, Raffaele Manni & Lino Nobili. (2018) Drugs Used in Parasomnia. Sleep Medicine Clinics 13:2, pages 191-202.
Crossref
Jana Ruda‐Kucerova, Jana Pistovcakova, Petra Amchova, Alexandra Sulcova & Alena Machalova. (2018) Prenatal exposure to modafinil alters behavioural response to methamphetamine in adult male mice. International Journal of Developmental Neuroscience 67:1, pages 37-45.
Crossref
Gustavo Bruniera Fernandes, Renata Carvalho Cremaschi, Cristóvão L.P. Mangueira, Sérgio Tufik & Fernando Morgadinho Coelho. (2018) Cataplexy plus presence of HLA-DQB1*0602 allele can predict Hypocretin-1 deficiency. Sleep Medicine 45, pages 146-147.
Crossref
Patrick J. Buckley & Chelsea T. Wolf. (2018) Psychosis in a 22-Year-Old Woman With Narcolepsy After Restarting Sodium Oxybate. Psychosomatics 59:3, pages 298-301.
Crossref
Eric Murillo-Rodríguez, André Barciela Veras, Nuno Barbosa Rocha, Henning Budde & Sérgio Machado. (2017) An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil. ACS Chemical Neuroscience 9:2, pages 151-158.
Crossref
O. V. Yakovleva, E. A. Lyashenko & M. G. Poluektov. (2018) Dysfunction of the orexin system in Parkinson's disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:6, pages 82.
Crossref
Hans-Peter Landolt, Sebastian C. Holst & Amandine Valomon. 2019. Sleep-Wake Neurobiology and Pharmacology. Sleep-Wake Neurobiology and Pharmacology 207 241 .
Tom MunyerErika Titus-Lay. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.